Literature DB >> 29804166

Treatment of intravitreal bevacizumab combined with focal laser photocoagulation in the case of macular telangiectasia type 2 with retinal arterial macroaneurysm.

Gökhan Demir1, Özgür Artunay2, Mehmet Emin Sucu2, Ali Demircan2, Dilek Yaşa2, Cengiz Alagöz2, Mevlüt Celal Öcal2.   

Abstract

Macular telangiectasia type 2 (Mac Tel 2) is a bilateral disease of unknown cause with characteristic changes of the retinal vasculature. To the best of our knowledge, we could not find any reported cases of Mac Tel 2 with retinal arterial macroaneurysm (RAM). Our aim is to report a case of Mac Tel 2 with RAM.

Entities:  

Keywords:  Focal laser photocoagulation; Macular telangiectasia; Retinal arterial macroaneurysm

Mesh：

Substances：

Year:  2018        PMID： 29804166     DOI： 10.1007/s10103-018-2548-z

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN： 0268-8921            Impact factor:   3.161


  17 in total

1.  Intravitreal ranibizumab therapy for retinal arterial macroaneurysm.

Authors:  Muhammet Kazim Erol; Berna Dogan; Deniz Turgut Coban; Devrim Toslak; Ayse Cengiz; Deniz Ozel
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis.

Authors:  D W Park; H Schatz; H R McDonald; R N Johnson
Journal:  Ophthalmology       Date:  1997-11       Impact factor: 12.079

3.  Retinal artery macroaneurysms: clinical and fluorescein angiographic features in 34 patients.

Authors:  R A Moosavi; K C S Fong; A Chopdar
Journal:  Eye (Lond)       Date:  2005-09-02       Impact factor: 3.775

Review 4.  Retinal arterial macroaneurysms.

Authors:  M F Rabb; D A Gagliano; M P Teske
Journal:  Surv Ophthalmol       Date:  1988 Sep-Oct       Impact factor: 6.048

5.  Idiopathic macular telangiectasia.

Authors:  Lawrence A Yannuzzi; Anne M C Bardal; K Bailey Freund; Kuan-Jen Chen; Chiara M Eandi; Barbara Blodi
Journal:  Arch Ophthalmol       Date:  2006-04

6.  Retinal arterial macroaneurysms: clinical, angiographic, and tomographic description and therapeutic management of a series of 14 cases.

Authors:  Armelle Cahuzac; Claire Scemama; Martine Mauget-Faÿsse; José-Alain Sahel; Benjamin Wolff
Journal:  Eur J Ophthalmol       Date:  2015-07-02       Impact factor: 2.597

7.  Monthly ranibizumab for nonproliferative macular telangiectasia type 2: a 12-month prospective study.

Authors:  Peter Charbel Issa; Robert P Finger; Kathrin Kruse; Sönke Baumüller; Hendrik P N Scholl; Frank G Holz
Journal:  Am J Ophthalmol       Date:  2011-02-19       Impact factor: 5.258

8.  Retinal structural changes associated with retinal arterial macroaneurysm examined with optical coherence tomography.

Authors:  Akitaka Tsujikawa; Atsushi Sakamoto; Masafumi Ota; Hideyasu Oh; Kazuaki Miyamoto; Mihori Kita; Nagahisa Yoshimura
Journal:  Retina       Date:  2009-06       Impact factor: 4.256

9.  The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project.

Authors:  Traci E Clemons; Mark C Gillies; Emily Y Chew; Alan C Bird; Tunde Peto; Maria Figueroa; Molly W Harrington
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-27       Impact factor: 4.799

10.  Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study.

Authors:  J D Gass; B A Blodi
Journal:  Ophthalmology       Date:  1993-10       Impact factor: 12.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.